MedPath

Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis

Not Applicable
Completed
Conditions
Hand Dermatosis
Interventions
Other: Mild, moisturizing hand cleanser
Registration Number
NCT00843466
Lead Sponsor
Wake Forest University
Brief Summary

The purpose of this study is to find out if the use of a hand cleanser that adds moisture to the skin will help improve skin rashes caused by frequent hand washing (hand dermatitis).

Detailed Description

The objective of this protocol is to evaluate compatibility and potential benefits of daily use of a marketed mild, moisturizing hand cleanser for subjects/patients who experience mild to moderate hand dermatitis induced by frequent cleansing.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Between 18 and 65 years of age
  • In general good health
  • Hands free of cuts and abrasions
  • Agree to adhere to the requirements listed in the informed consent
  • Willing and able to use a mild, moisturizing, non-antibacterial cleanser for all hand washing purposes for the duration of the test period
  • Willing to refrain from participating in any other clinical research trial for the duration of the study
Exclusion Criteria
  • Documented allergies to study product components, soaps, latex, or fragrances
  • History of the following conditions which may affect the response of the skin or the interpretation of the results: insulin dependent diabetes, or peripheral vascular diseases
  • Participating in a concurrent clinical study involving treatment of your hands
  • Currently using a prescription medication for hand dermatitis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mild moisturizing Hand CleanserMild, moisturizing hand cleanserThe test group will be provided with a mild moisturizing hand cleanser for all hand cleansing needs during the duration of the study.
Primary Outcome Measures
NameTimeMethod
Investigator Global AssessmentWk 4

Changes in global disease severity on a scale from 0-4 with 0 being clear and 4 being severe

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wake Forest University Health Sciences Dermatology

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath